News
November 6, 2007 – Philips Medical Systems at AHA highlighted its recently introduced iE33 Live 3D TEE, an echo system ...
November 05, 2007
News
November, 2007 - An ECG that fits in the palm of your hand, Mortara Instrument’s ELI 10 hand-held electrocardiograph includes a variety of advanced clinical and communication features.
November 05, 2007News
November 4, 2007 - Itamar Medical announced that four presentations at AHA, including one from the Framingham Heart ...
November 05, 2007Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026News
November 6, 2007 - Acusphere Inc. announced that Imagify Perfusion Stress Echo, an investigational new drug developed to ...
November 05, 2007News
November, 2007 - GE Healthcare featured products in cardiovascular ultrasound, interventional cardiology and ...
November 05, 2007Technology
November 6, 2007 – Philips Medical Systems highlighted its recently introduced iE33 Live 3D TEE, an echo system designed to address a growing requirement with complementary 2D and volumetric Live 3D imaging and quantification tools that help clinicians answer questions on structure, efficiency, size and function related to cardiac disease management.
November 05, 2007Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026News
November 2007 - Boston Scientific, a manufacturer of intravascular ultrasound (IVUS) imaging technology, unveiled new ...
November 05, 2007Technology
Pinyons Medical Technology offers the FDA-cleared PowrSyringe Injector, a disposable hand-held device designed to offer ergonomic and mechanical advantages to inject and aspirate fluids including use in angiography. The Injector’s crossing handles hinge to the syringe barrel and plunger to advance the plunger into the barrel when the handles are squeezed.
November 04, 2007News
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with similar safety compared to a bare metal stent at five-year follow-up, according to data presented at the American Heart Association Scientific Session 2007.
November 04, 2007Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...
November 04, 2007News
November 5, 2007 - According to late-breaking clinical trial results presented at the American Heart Association’s ...
November 04, 2007News
November 5, 2007 – Boston Scientific Corp. highlighted at the American Heart Association conference its new Stentplus ...
November 04, 2007Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...
November 03, 2007News
November 4, 2007 – The antiplatelet drug prasugrel offered greater benefit than current, standard therapy for patients ...
November 03, 2007News
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial presented at the American Heart Association’s Scientific Sessions 2007.
November 03, 2007